주식/증권 📈 긍정적 NeoGenomics anticipates $802M-$806M 2026 revenue as it targets mid-20% NGS growth and adjusts pharma expectations Seeking Alpha - Market News 2026/07/29 02:14:05 7회 원문 기사 보기